# Phyllanthus emblica

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/phyllanthus-emblica
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 8 / 10
**Category:** Ayurveda
**Also Known As:** Emblica officinalis, Amla, Indian gooseberry, Amalaki, Dhatri, Emblic myrobalan, Nellikkai

## Overview

Phyllanthus emblica contains high concentrations of vitamin C and ellagitannins that provide potent antioxidant effects. The fruit works primarily through reducing [oxidative stress](/ingredients/condition/antioxidant) and supporting [endothelial function](/ingredients/condition/heart-health) in blood vessels.

## Health Benefits

• Improves endothelial function and [cardiovascular health](/ingredients/condition/heart-health) - RCT (n=59) showed significant improvement in reflection index (P<0.001) after 12 weeks
• Reduces [oxidative stress](/ingredients/condition/antioxidant) and [inflammation](/ingredients/condition/inflammation) markers - Clinical trial demonstrated lowered biomarkers with both 250mg and 500mg twice daily doses
• Supports COVID-19 recovery as adjunct therapy - RCT (n=61) showed reduced hospital stay (4.44 vs 7.18 days, P<0.001) and improved oxygen saturation
• Enhances lipid profile - Human studies showed improvements in cholesterol markers alongside cardiovascular benefits
• Modulates gut microbiota - Animal studies indicate increased beneficial Lactobacillus and decreased harmful bacteria

## Mechanism of Action

Phyllanthus emblica's bioactive compounds, particularly ellagitannins and ascorbic acid, scavenge free radicals and inhibit [lipid peroxidation](/ingredients/condition/antioxidant). The fruit's antioxidants enhance nitric oxide bioavailability in endothelial cells, improving vascular function. Additionally, its polyphenolic compounds modulate [inflammatory pathway](/ingredients/condition/inflammation)s by inhibiting NF-κB activation.

## Clinical Summary

A randomized controlled trial with 59 participants demonstrated significant improvement in [endothelial function](/ingredients/condition/heart-health) after 12 weeks of supplementation (P<0.001). Clinical studies have tested doses of 250mg and 500mg twice daily, both showing reductions in [oxidative stress](/ingredients/condition/antioxidant) biomarkers. The evidence base consists primarily of small-scale human trials and preliminary studies. More large-scale, long-term trials are needed to establish definitive therapeutic effects.

## Nutritional Profile

**Bioactive Compounds:** Exceptionally rich in vitamin C (approximately 600–1,800 mg per 100g fresh fruit, though values vary significantly by cultivar and processing; heat-stable due to complexation with tannins). Contains a diverse polyphenol profile including hydrolyzable tannins — notably emblicanin A (37% of tannin fraction), emblicanin B, punigluconin, and pedunculagin — as well as ellagic acid (approx. 1.6–2.4% dry weight), gallic acid (approx. 1.3–1.7% dry weight), and corilagin. **Flavonoids** include quercetin, kaempferol, and their glycosides. **Macronutrients (per 100g fresh fruit):** Carbohydrates ~10–14g (including dietary fiber ~3.4–4.3g, primarily pectin and hemicellulose), protein ~0.5–0.9g, fat ~0.1–0.5g. **Minerals:** Iron ~1.2–3.0 mg, calcium ~25–50 mg, phosphorus ~20–27 mg, chromium (trace, potentially relevant to glycemic effects), zinc ~0.12 mg, magnesium ~10–13 mg per 100g fresh fruit. **Vitamins:** Carotenoids (β-carotene ~9–13 µg/100g), riboflavin ~0.01 mg, thiamine ~0.03 mg, niacin ~0.2 mg per 100g. **Other bioactives:** Superoxide dismutase (SOD)-like activity compounds; mucic acid (1,4-lactone); phyllemblin (a unique diarylbutanoid); low molecular weight organic acids including citric, malic, and succinic acids. **Bioavailability notes:** The tannin-vitamin C complex confers notable thermal stability, preserving [antioxidant activity](/ingredients/condition/antioxidant) through traditional Ayurvedic processing methods (e.g., churna, amalaki rasayana). Ellagitannins are metabolized by gut microbiota into urolithins (A and B), whose production varies by individual enterotype, significantly affecting systemic bioavailability. Gallic acid demonstrates relatively high oral bioavailability (~30–40% in animal models). Standardized commercial extracts are typically titrated to 35–60% total polyphenols or specific tannin content (emblicanin A+B), with clinical doses commonly ranging from 250–1,000 mg of extract daily (equivalent to approximately 5–20g of fresh fruit depending on extract ratio). The high ascorbic acid content may enhance non-heme iron absorption from co-consumed foods.

## Dosage & Preparation

Clinically studied dosages include 250mg twice daily (500mg/day) and 500mg twice daily (1000mg/day) of aqueous extract for 12 weeks, with both doses showing efficacy. CAPROS standardized extract has been used in [cardiovascular](/ingredients/condition/heart-health) studies, though specific dosage was not detailed. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Phyllanthus emblica is generally well-tolerated with minimal reported side effects in clinical studies. High doses may cause gastrointestinal upset due to its high vitamin C content. The supplement may enhance the effects of anticoagulant medications due to its [cardiovascular](/ingredients/condition/heart-health) benefits. Pregnant and breastfeeding women should consult healthcare providers before use due to limited safety data.

## Scientific Research

Clinical evidence includes a randomized controlled trial (n=59) showing significant [endothelial function](/ingredients/condition/heart-health) improvement with 250-500mg twice daily for 12 weeks (PMID: 31060549). A COVID-19 adjunct therapy trial (n=61) demonstrated shorter hospital stays and improved clinical outcomes (PMID: 35093510). Additional RCT evidence exists for cardiovascular risk reduction in overweight adults using CAPROS standardized extract (PMID: 25756303).

## Historical & Cultural Context

Phyllanthus emblica has been used for centuries in Ayurvedic medicine (as Emblica officinalis) for immune-modulation, [anti-aging](/ingredients/condition/longevity), and various therapeutic applications. It also appears in Persian medicine contexts as an add-on treatment for infections, with reviews documenting extensive experimental and clinical support for traditional uses.

## Synergistic Combinations

Vitamin C, Curcumin, Quercetin, Ashwagandha, Green Tea Extract

## Frequently Asked Questions

### What is the effective dosage of Phyllanthus emblica?

Clinical studies have used doses ranging from 250mg to 500mg twice daily. The 12-week cardiovascular study showing significant benefits used standardized extract doses. Most commercial supplements contain 500-1000mg per serving.

### How long does it take for Phyllanthus emblica to work?

Cardiovascular benefits were observed after 12 weeks of consistent supplementation in clinical trials. Antioxidant effects may begin within days to weeks. Individual responses vary based on baseline health status and dosage used.

### Can Phyllanthus emblica interact with blood pressure medications?

The supplement may enhance cardiovascular effects of blood pressure medications due to its endothelial function benefits. Patients taking antihypertensive drugs should monitor blood pressure closely. Consult a healthcare provider before combining with cardiovascular medications.

### Is Phyllanthus emblica the same as amla?

Yes, Phyllanthus emblica is the scientific name for amla, also called Indian gooseberry. All three terms refer to the same fruit used in Ayurvedic medicine. Commercial supplements may use any of these names interchangeably.

### What are the main active compounds in Phyllanthus emblica?

The primary bioactive compounds include ellagitannins, gallic acid, and exceptionally high vitamin C content. Ellagitannins provide the main antioxidant activity while ascorbic acid supports immune function. These compounds work synergistically to provide therapeutic benefits.

### What does clinical research show about Phyllanthus emblica's effects on cardiovascular health?

A randomized controlled trial (n=59) demonstrated that Phyllanthus emblica significantly improved arterial reflection index, a key marker of endothelial function, after 12 weeks of supplementation (P<0.001). This suggests the ingredient may enhance blood vessel flexibility and reduce cardiovascular stiffness through its potent antioxidant mechanisms. The improvement in endothelial function is one of the most well-documented benefits in clinical research for this herb.

### Who should consider taking Phyllanthus emblica based on current research?

Individuals seeking to reduce oxidative stress and inflammation markers may benefit most, as clinical trials have shown significant reductions in inflammatory biomarkers at doses of 250mg and 500mg twice daily. Those recovering from acute respiratory infections, particularly COVID-19, may find it valuable as an adjunct therapy, with research showing reduced hospital stay duration (4.44 vs 7.18 days). People concerned about cardiovascular health and endothelial function are also prime candidates based on demonstrated improvements in arterial stiffness markers.

### How does Phyllanthus emblica reduce inflammation compared to its individual active compounds?

Phyllanthus emblica contains multiple synergistic active compounds that work together to lower inflammatory and oxidative stress biomarkers more effectively than isolated compounds alone. The whole-plant extract demonstrated efficacy at relatively modest doses (250–500mg twice daily) in clinical settings, suggesting that the combination of gallic acid, ellagic acid, and other polyphenols produces enhanced anti-inflammatory effects. This synergistic action is why the whole extract is preferred in research studies rather than isolated single compounds.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*